KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Net Margin (2016 - 2025)

Pfizer (PFE) has disclosed Net Margin for 17 consecutive years, with 0.17% as the latest value for Q2 2025.

  • Quarterly Net Margin rose 4.0% to 0.17% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 0.05% through Dec 2025, up 4.0% year-over-year, with the annual reading at 0.04% for FY2025, 9.0% down from the prior year.
  • Net Margin for Q2 2025 was 0.17% at Pfizer, up from 1.81% in the prior quarter.
  • The five-year high for Net Margin was 0.17% in Q2 2025, with the low at 1.81% in Q3 2024.
  • Average Net Margin over 5 years is 0.25%, with a median of 0.03% recorded in 2022.
  • The sharpest move saw Net Margin plummeted -1030bps in 2021, then surged 137bps in 2022.
  • Over 5 years, Net Margin stood at 0.05% in 2021, then tumbled by -72bps to 0.09% in 2022, then plummeted by -716bps to 0.76% in 2023, then crashed by -139bps to 1.81% in 2024, then skyrocketed by 109bps to 0.17% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 0.17%, 1.81%, and 0.13% for Q2 2025, Q3 2024, and Q2 2024 respectively.